FPH will be doing almost 2 b sales with profits of around 0.5b eps of 0.85 in this full covid year ...going forward also a big boost to future growth due to covid exposure of their products to many many new doctors and patients . Sector P/E is 45 as its niche healthcare showing steady growth and better prospects ahead with ageing world population . They have patent products and invest 10% in R&D regularly . No wonder they were No 1 company of NZ 2020 .
FPH has given 14 earnings upgrades in last 3 years with more coming in Feb 2021
RYM value moves with property prices too for obvious reasons ...it went to $ 6 in march now ...